On 19 June 2025, Oman became the latest country to join the growing network of VigiMobile users. The Ministry of Health, through its Drug Safety Centre, announced the official launch of the mobile reporting tool, opening up new possibilities for patients and health professionals to share their experiences with medicines and vaccines.
VigiMobile is designed to make adverse event reporting simple, fast, and accessible. Reports can be filled out on a smartphone, tablet, or desktop – even without an internet connection. Once reconnected, the reports are transmitted securely to the Drug Safety Centre, where they are reviewed and analysed before being shared with VigiBase, WHO’s global database of adverse event reports for medicines and vaccines.
Developed by Uppsala Monitoring Centre, VigiMobile has been customised by the Ministry of Health in Oman with local branding, Arabic language support, and user-friendly drop-down menus. These features make the reporting process accessible and intuitive for everyone in the Sultanate, whether they are healthcare professionals or members of the public. By lowering barriers to adverse event reporting, the Ministry hopes to increase both the number and quality of reports. This, in turn, strengthens the country’s ability to detect potential safety issues early and act on them quickly.
The offline functionality is particularly valuable in regions where internet coverage is limited. People can still record their experiences with medicines or vaccines and submit them later, ensuring that no important safety information is lost.
To make it even easier to access the app, the Ministry of Health has shared the QR code links to VigiMobile and step-by-step guidance on its Instagram and X (formerly twitter) social media accounts.
Furthermore, the Drug Safety Centre is pairing the launch with awareness campaigns and training sessions for healthcare providers. Public information materials are also being prepared to encourage patients to use the app and see themselves as active partners in medicines safety.
With VigiMobile now part of Oman’s pharmacovigilance toolkit, the country joins a growing number of nations adopting mobile reporting as a way to bring patients’ voices closer to decision-making regarding medicines and vaccines. It is another step toward a more responsive, connected, and patient-centred safety system.